Monday, July 31, 2017

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Set to Benefit as Study Shows More Benefits of Cannabidiol

- Cannabidiol (CBD) combats anxiety, inflammation, nausea and vomiting

- Low side-effect profile means high doses of cannabidiol can be used for treatment of schizophrenia, dementia, diabetes and nausea

- Lower doses promote and maintain health with anti-oxidative, anti-inflammatory and neuroprotective effects


Lexaria Bioscience Corp. set to benefit from increasing interest in CBD as patented technology improves taste, rapidity and effectiveness of bioactive compounds including cannabinoids
A new scientific review of the safety and side effects of cannabidiol confirms and expands on the myriad known health benefits of cannabidiol and the compound’s lack of side effects.

The review, titled “An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies,” was published in the journal Cannabis and Cannabinoid Research in June. To view the full publication, visit: http://dtn.fm/cbd-clinical-overview-pdf.

Cannabidiol has a number of beneficial effects, the study states; it is anti-inflammatory, anxiolytic, antiemetic and antipsychotic. This can only increase the demand for cannabidiol (CBD) products and is good news for Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP). Lexaria has patented a revolutionary lipophilic delivery method which allows accurate, timely delivery of cannabinoids without the need for users to smoke, vape or otherwise inhale the substance.

Lexaria out-licenses its proprietary technology for improved taste, increased speed and efficiency in the delivery of bioactive compounds, including cannabinoids. The special manufacturing process infuses CBD within lipids, which form the basis of the human endocannabinoid system. Lexaria Bioscience’s new process masks the undesirable taste of cannabidiol, which eliminates the need for added sugar and results in a healthier product.

The review’s authors, Iffland Kerstin and Grotenhermen Franjo, concluded that along with the beneficial effects, the safety profile of CBD is excellent. Chronic use and high doses of up to 1,500 mg per day have repeatedly shown to be well tolerated. Cannabidiol does not alter physiological parameters such as heart rate and blood pressure and does not adversely affect psychological and psychomotor functions, food intake or gastrointestinal transit.

The study’s authors reviewed clinical data and animal studies to extend and update a comprehensive survey by Bergamaschi et al. in 2011 on CBD safety and side effects; they concluded that CBD has a much better side effect profile than other drugs used for the treatment of epilepsy and psychotic disorders.

Several studies have shown cannabidiol to be effective in the treatment of epilepsy. In one study, CBD treatment reduced seizures by 45% in 261 young children who were not receiving relief from standard medications. In another study, CBD reduced the frequency of seizures by 39% in therapy-resistant epilepsy patients.

Cannabidiol has also been shown to have anti-anxiety effects equivalent to a standard dose of imipramine, a selective serotonin reuptake inhibitor sold as Tofranil and commonly used to treat anxiety and depression.

Studies have found that CBD reduces inflammation in the gastrointestinal system, treats symptoms of multiple sclerosis and helps with the management of glaucoma.

According to the study review, cannabidiol has also been shown to:

- help with cannabis withdrawal

- reduce heroin-seeking behaviors

- reduce psychotic symptoms in Parkinson’s patients

- reduce the likelihood of developing diabetes

- positively modulate the immune system in diseases such as multiple sclerosis, arthritis and diabetes

- reduce amyloid beta neuro-inflammation and prevent the development of a social recognition deficit in Alzheimer’s disease.

- reduce swelling and inflammation in arthritis

- prevent or slow the spread of certain types of aggressive cancer cells

- reduce weight gain

- reduce symptoms of psychiatric disorders such as psychosis and bipolar disorder


Cannabidiol is not the only substance which can be formulated and delivered via Lexaria’s revolutionary delivery method; the patented technology can be used for delivery of nicotine, vitamins, analgesics and a variety of other substances. Tests by an independent, third-party lab show that Lexaria’s technological process and lipid formulation improve intestinal absorption by as much as 500%.

Patents have been issued to the company in the U.S. and Australia protecting Lexaria’s intellectual property for the edible delivery of all non-psychoactive cannabinoids, including cannabinoid edibles. A variety of food and beverage formats are protected by the patent, including tea, coffee, cocoa powder, fresh foods and meats, dairy products, pastas, breads, seeds, nuts, spices, herbs, candies, flavorings and more.

Lexaria is primarily a B2B enterprise, and it is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the U.S., and abroad.

For more information, visit the company’s website at www.LexariaEnergy.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Establishment of Hemp Education Center

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned subsidiary, ChineseHempOil.com, Inc., has established a Hemp Education Center in San Gabriel, California. Through this club-style education center, the company aims to provide valuable information to those who want to learn more about the potential health benefits of non-industrial hemp and hemp-derived cannabidiol (CBD). “I am delighted about the possibilities of our new Hemp Education Center,” Warren Wang, CEO and founder of CIIX, stated in the news release. “In recognition of the unprecedented opportunities in the legal non-industrial hemp industry, CIIX expanded its business to capitalize on the growing demand for hemp health products. Our new club-style Hemp Education Center will build awareness of the hemp industry and our brand while laying the groundwork for ChineseHempOil.com to be recognized as the premiere name in hemp products within the Chinese-speaking market.”

To view the full press release, visit http://dtn.fm/6xQl3

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Friday, July 28, 2017

QualityStocksNewsBreaks – Patriot One Technologies (PTOTF) Offers Game-Changing Tool in Fight Against Terrorism

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is disrupting the security market with PATSCAN, a novel weapons detection technology that uses state-of-the-art microwave radar technology that is linked to machine algorithms. Patriot One has developed PATSCAN in collaboration with McMaster University of Canada, and the system offers a pioneering tool in the fight against terrorism with its ability to be covertly placed and scan for weapons without subjects even knowing they’re being scanned—no stop-and-scan procedures or invasions of privacy. An excerpt from a recent article further detailing this position is as follows:

“Earlier this year, the company announced the Security Industry Association (SIA) had recognized it as winners of the Anti-Terrorism / Force Protection category in the New Product Showcase (NPS) component of the ISC West industry trade show and conference in Las Vegas, Nevada. SIA NPS judges are highly skilled and experienced in security technology design and application and are required to have a minimum of 10 years experience in the selection, purchase and or installation of products within the category that they are judging. The PATSCAN has, so far, achieved a 94 percent true positive detection, which is far ahead of traditional metal detector rates. Patriot’s order book is growing, and inquiries from potential clients and distributors continue to pour in. Last month, one such inquiry, from Down Under, blossomed into a new partnership. Patriot One announced it had entered into a reseller agreement with accredited national systems integration experts Aotea Security (NZ) Ltd. of Dunedin, New Zealand. Aotea Security is the security specialist arm of the Aotea Group of companies, which provides New Zealand’s only truly nationwide solution for electronic security, electrical, fire, and communications services.”

To view the full article, visit http://dtn.fm/sPB4e

About Patriot One Technologies, Inc.

Patriot One has developed PATSCAN CMR™ the next generation of its award-winning Patriot One Technologies™ NForce CMR1000 software and radar solution. PATSCAN CMR is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system as an effective tool to combat active shooter threats before they occur. Designed for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The company’s motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit https://patriot1tech.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Algae Dynamics Corp. (ADYNF) Developing Potential Breakthrough Fortified Formulas to Boost Human Endocannabinoid System

As debates continue over the legalization of marijuana, many individuals who have never touched plant-derived cannabinoids (phytocannabinoids) do not realize that their bodies naturally produce endocannabinoids, which play an essential mediating role in various human physiologic systems. Recent studies have shown that the production of endocannabinoids is boosted by fatty acids, and Algae Dynamics (OTCQB: ADYNF) has begun developing fortified formulas of omega-3s and cannabis oil that could potentially boost the function of the human body’s endocannabinoid system.

“The products under development by Algae Dynamics promise to pack a powerful therapeutic punch, combining the virtues of omega-3s and cannabinoids. Algae Dynamics’ algae omega-3 oil has a high concentration of DHA, which is in demand by the growing multi-billion dollar food and beverage and health care sectors. The North American omega-3 market was estimated to be $4.0 billion in 2013 and is expected to reach $5.9 billion by 2019, growing at a CAGR of 6.5% from 2014 to 2019. Supplements are the largest application segment driving North America’s omega-3 market, and the cannabinoid market is just as vibrant. It is expected to cross $2 billion in consumer sales by 2020. It seems no matter which market Algae Dynamics chooses for its products, success is almost guaranteed.”

To view the full article, visit http://dtn.fm/FXl5h

About Algae Dynamics

Algae Dynamics is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. To assist in this development, Algae Dynamics engaged two Canadian universities to provide research, focusing on the use of cannabis oil in the context of cancer and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. Algae Dynamics intends to utilize this research to develop products that combine the significant health benefits of Omega-3 fatty acids derived from algae oil with extracts from cannabis oil for the rapidly growing medical and non-medical markets in Canada and globally. The company has developed strategic relationships with licensed producers of cannabis to ensure a source of cannabis oil. Algae Dynamics’ product development efforts are designed in the near-term for over-the-counter nutraceuticals, and in the longer-term for patented medicines. The company’s recent initiatives are an extension of its previous plan, which was focused solely on commercialization of its proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. For more information, visit the company’s website at http://www.algaedynamics.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (LXRP) Well-Positioned for Growth as First Mover in Canada’s Cannabinoid Market

Among players in Canada’s emerging cannabinoid market, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is well-positioned for growth. Lexaria is a revenue-generating company engaged in developing and out-licensing proprietary technology for delivering bioactive compounds, including cannabinoids, and the company’s products utilize this patented lipophilic technology, which has been proven to enhance the bioavailability of orally ingested cannabinoids and also improve their taste.

“With full legalization expected in 2018, the Canadian market for cannabis extracts and oils is expected to top C$1.6 billion by 2020. Lexaria is at the forefront of innovation in the biosciences sector as pioneering biopharmaceutical companies in Canada and elsewhere work to research and develop healthy cannabinoid products. Investment capital in these “plant-to-bloodstream” companies is expected to grow exponentially. As a first mover into this space, Lexaria is well-positioned for increasing market share and revenue.”

To view the full article, visit http://dtn.fm/Vb8Ru

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit www.LexariaBioscience.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Thursday, July 27, 2017

ProBility Media Corp.’s (PBYA) E-Learning Brand Is Transforming Businesses

- July acquisition of W Marketing further expanded the ProBility educational brand into the U.S. electrical industry, a $130 billion market

- Products include virtual reality products for 3D animation and modeling training, thanks to a 51 percent ownership stake in ProBility Immersive Technologies

- ProBility Safety Academy now offers courses in private security, public safety, criminal justice and police science


An EdTech company serving numerous career-intensive fields, ProBility Media Corp. (OTCQB: PBYA) is offering businesses full-service training and career advancement resources. Small- and medium-sized businesses in these areas have traditionally had to rely on disparate e-learning resources. Now, ProBility is offering high quality materials that are consistent with those accessible by enterprise-level organizations. The company has recently expanded into many fields, serving businesses of all sizes in multiple industries with materials for training and career advancement.

ProBility closed an acquisition of W Marketing, Inc. in July 2017, expanding its reach into the electrical industry, valued at roughly $130 billion in the U.S. The resources available now include educational courses and exam preparation materials that are compliant with all relevant standards. They can potentially be used by the tens of thousands of electrical contractors in the country and by hundreds of thousands of electrical workers who install, maintain, and repair lighting, power, and communications systems.

The company’s educational products extend all the way into the virtual reality realm. In a strategic joint venture with Industrial3D Corp., ProBility Immersive Technologies was formed to create content focused on the virtual reality and interactive media content trades. Initially, the company added a library with over 200 industry-specific intellectual property animations. It also offers subscription services to energy and industrial sector employers.

Another recent addition to the company’s brand is ProBility Safety Academy. It is a complete online security and safety training institution spanning many fields, from private security to public safety, police science and criminal justice. Books, course content, and practice tests are open to students and professionals in any part of the safety and security industry. A joint venture with Ranger Guard and Investigations, the academy is accredited in the state of Texas.

ProBility isn’t just focusing on expanding its e-learning reach into various industries. Its recent letter of intent to purchase Cranbury International, which exports educational/reference materials to South and Central America and Caribbean nations, is evidence that the company is looking to expand internationally. A future acquisition, expected to close within 30 days (http://dtn.fm/F4cWk), could give ProBility access to private sector and government markets in Mexico, Brazil, Columbia, and other regions. Cranbury represents about 40 major publishers.

The company serves skilled trades through numerous divisions, including Brown Technical Publications Inc.; Brown Technical Media Corp.; Brown Book Shop, Inc.; One Exam Prep, LLC; and National Electrical Wholesale Providers. ProBility Safety Academy is one of these divisions as well. The available e-learning products for career training and advancement and compliance span over 60 trades, and the company continues to work toward expanding its scope.

For more information about the company, visit www.ProBilityMedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com (CIIX) Takes Aim at North American, Chinese Cannabidiol Markets

- CIIX’s multi-prong approach offers opportunity for investors

- Company to launch hemp-infused skin care product line in China

- Brick-and-mortar store planned for California, CBD biotech incorporated in Canada

- Online CBD store serves global Chinese-speaking population; Yelp style app helps Chinese-speakers find U.S. medical marijuana dispensaries


ChineseInvestors.com, Inc. (OTCQB: CIIX) is offering a unique opportunity for investors as the company pursues a multi-pronged approach to conquering the rapidly expanding global markets in cannabidiol products and the medical marijuana space in Canada. The company aims to be the world’s leading publicly traded Chinese nutritional company.

Globally, ChineseInvestors.com targets the global Chinese-speaking population with an online CBD store offering hemp-based products. Cannabidiol, or CBD, is a non-psychoactive cannabinoid that research is showing has numerous health benefits including the treatment of epilepsy. Many other CBD health benefits are being discovered, and the market is rapidly expanding.

The company announced earlier this week (http://dtn.fm/Br7Xj) that its subsidiary, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). The product line is expected to launch in late August or early September and will position CBD Biotechnology as a first-mover in China’s CBD-based skin care market.

Another part of the company’s strategic plan to penetrate the Chinese-speaking market is the launch of a ‘Yelp’ style mobile app to help users locate dispensaries and discuss cannabis products in the U.S., along with a CBD retail store in the predominantly Chinese community of San Gabriel, California, where the company’s headquarters are located.

Other exciting developments from ChineseInvestors.com include the announcement of a bitcoin payment solution for its wholly-owned subsidiary, ChineseHempOil.com, Inc., and the company’s effort to become the first company in China to employ CBD oil as a treatment to relieve suffering for epilepsy and Alzheimer’s patients. The company plans to continue studying CBD oil’s efficacy as a treatment for these diseases and invest in CBD drug R&D enterprises, with an end goal of developing a variety of CBD drugs to treat epilepsy and Alzheimer’s.

Marijuana use is illegal in China, but cannabis-based oils, including hemp-based CBD, are legal, giving CIIX access to a market of almost two billion potential customers.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Research Published in the European Journal of Pain

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the publication of company-sponsored research in the European Journal of Pain. The article, titled ‘Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation’, highlights results from a study co-sponsored by InMed and the MITACS Elevate Postdoctoral Fellowship Program. “Developing a topically-applied product that can provide localized relief of chronic and/or acute severe pain, without central side effects, remains one of the ‘holy grails’ in the field of analgesia,” Dr. Sazzad Hossain, chief scientific officer of InMed, stated in the news release. “This study sets the stage for advanced work in various pain models to explore the role of several cannabinoid compounds, applied as topical agents, to target the CB1 and other pain-related receptors.” The study results, which can be reviewed at http://dtn.fm/hdQn1, suggest that peripheral application of cannabinoids targeting the natural endocannabinoid receptor system may provide a valuable approach in treating severe pain.

To view the full press release, visit http://dtn.fm/xAg76

About InMed

InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the company. For more information, visit www.inmedpharma.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Wednesday, July 26, 2017

Algae Dynamics Corp.’s (ADYNF) Therapeutic Fortified Formulas Likely to Boost Endocannabinoid System

- Commercializing proprietary BioSilo® algae cultivation system

- Developing therapies that combine omega-3s and cannabinoids

- Poised to enter billion dollar markets


If you think you haven’t had cannabinoids because you’ve never used cannabis, you are completely mistaken. You may not have ‘touched’ plant-derived cannabinoids (phytocannabinoids), but it would have been biologically impossible to escape the ones produced by your body (endocannabinoids). Endocannabinoids play an essential mediating role in a number of human physiologic systems. They promote a Goldilocks internal environment, a mean between excess and deficiency in a variety of functions and areas, and recent scholarship has shown that their production is enhanced and fostered by fatty acids, the kind used by Algae Dynamics Corp. (OTCQB: ADYNF). As a result, ADYNF has begun to develop fortified formulas of omega-3s and cannabis oil that may boost the functioning of the human endocannabinoid system.

Discovery of what is now known as the endocannabinoid system has a peculiar history. It is perhaps the only known human physiologic system that is named after a plant, and that’s all because of chronology. A number of substances isolated from the cannabis plant were later found to be produced by the human body. First identification and isolation of the two major cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), is attributed to Raphael Mechoulam and his colleague Y. Gaoni in Israel in 1964. Mechoulam, whose discovery and further research into cannabis has earned him the moniker, ‘Father of Cannabis’, was also part of a team that, in 1992, discovered the endocannabinoid system.

This physiologic system plays a vital role in maintaining human health. Endocannabinoids and their receptors permeate the human body. They can be found in the brain, in various organs, in connective tissue, in glands and in immune cells. Their main function appears to be stabilizing our internal environment, freeing it from the dangerous volatility of the external world. Currently, the two best understood endocannabinoids are anandamide and 2-arachidonoylglycerol (2-AG), studies of which have uncovered a number of medical benefits they may have. Anandamide, for example, inhibits the proliferation of breast cancer cells and appears to retard the memory decline associated with Alzheimer’s disease. These encouraging findings suggest that phytocannabinoids offer a ‘natural’ way to treat a variety of ailments, including multiple sclerosis (MS), arthritis, hypertension, memory loss, pediatric epilepsy and neuropathic pain.

Research into cannabis and development of therapeutic products goes on. In Canada, as legalization looms, industry professionals are divided on whether there should be a legal distinction between medical and recreational cannabis. A recent article on CBC News Health reports comments by two researchers, who believe that medicinal and recreational cannabis should be separate (http://dtn.fm/aX2Di). They argue that a dual-stream approach would decrease the stigma associated with cannabis use for medicinal purposes, since, for example, it would be sold at a pharmacy rather than a general retailer. Dual-stream would also protect ‘the supply of strains of medical cannabis that have desirable effects for patients, such as lower THC strains sometimes used to treat children who suffer from seizures’ and also increase clinical research into the therapeutic benefits of cannabis.

The products under development by Algae Dynamics promise to pack a powerful therapeutic punch, combining the virtues of omega-3s and cannabinoids. Algae Dynamics’ algae oil is high in omega-3s DHA/DPA, which is in demand by the growing multi-billion dollar food and beverage and health care sectors. The North American omega-3 market was estimated to be $4.0 billion in 2013 and is expected to reach $5.9 billion by 2019, growing at a CAGR of 6.5% from 2014 to 2019. Supplements are the largest application segment driving North America’s omega-3 market, and the cannabinoid market is just as vibrant. It is expected to cross $2 billion in consumer sales by 2020. It seems no matter which market Algae Dynamics chooses for its products, success is almost guaranteed.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

American Energy Partners, Inc. (XFUL) – Who Says Oil and Water Don’t Mix?

- Fracking now accounts for half of oil production, and 90 percent of new wells are fracked

- Water remains a limited resource, yet is vital to fracking process

- American Energy Partners’ vertically-integrated subsidiaries deliver solutions


No matter what the future may hold, for now, the world runs on oil. Oil is the life blood of the world’s economic development, and obtaining oil has been an ongoing quest since long before the invention of the internal combustion engine. The first successful oil well in the U.S. was drilled near Titusville, Pennsylvania, in 1859. From there, drilling moved rapidly across the entire country, and an oil boom ensued. U.S. crude oil production peaked in 1970 at 9.64 million barrels daily, but production waned after that until the advent of advanced horizontal drilling techniques and hydraulic fracking.

Hydraulic fracking is a sophisticated drilling technology that has exponentially expanded petroleum and natural gas production in the United States. Fracking now accounts for over half of U.S. oil production and two-thirds of natural gas production in the country, making the U.S. the largest natural gas producer in the world. However, large use of water in the fracking process creates controversy. Water is vital to the hydraulic fracking process, and competition for water is fierce.

In an interesting historical twist, Converde Energy USA, Inc. (OTC: XFUL), d/b/a American Energy Partners, Inc., and its subsidiaries are providing solutions in the same area where some the country’s first oil wells were drilled. The company’s sweet spot is where energy production and water meet technology. XFUL’s subsidiaries target energy operations to design, build and operate regional water treatment facilities that serve both the industrial and energy sectors. Together, American Energy Partners and its subsidiaries comprise an integrated vertical that sources, scrubs, and supplies water to mining, oil and gas, power, and other industrial concerns.

The company’s Hydration Corporation of PA (HCPA) subsidiary possesses the technical know-how to source, implement and distribute reclaimed water at a profit. HCPA’s patent-pending process delivers among the highest energy yields possible from a wide range of water-bearing assets and does so with one of the lowest capital expenditures of any other known water process.

XFUL’s American Energy Solutions subsidiary provides off-the-shelf and custom-designed treatment technologies across its customer base and augments HCPA’s low-cost treatment and distribution solutions, while the company’s Gilbert Oil & Gas Company subsidiary is its oil and gas business arm that leverages relationships and experience to source drilling, operating, and partnership opportunities in the oil and gas space. Gilbert Oil & Gas is positioned to not only become a strong customer of the other subsidiaries but also to attract other customers and open new markets.

With almost 90% of all new U.S. onshore oil and gas hydraulically fractured, demand for XFUL’s integrated oil and water services could surge. Who says oil and water don’t mix?

For more information, visit the company’s website at www.AmericanEnergy-Inc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Tuesday, July 25, 2017

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Patented Cannabinoid Delivery System Approved

- Patented lipophilic delivery system increases bio-absorption

- Patents cover broad range of lipophilic bio-actives, including cannabinoids, vitamins, other pharma

- 19 patents filed across 44 countries

- First international patent issued and approved in Australia


Any argument over the efficacy of medicinal marijuana is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://dtn.fm/C9Sao). However, the human gastrointestinal tract just doesn’t absorb cannabinoids effectively, and much of what is ingested is simply excreted by the body. Subsequently, onset times and effectiveness vary wildly.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has patented and licenses a novel delivery system which infuses organically sourced hemp oil into the molecules of other substances. The system utilizes lipids, which form the basis of the human endocannabinoid system, increasing both absorption and bioavailability of payload molecules. Lexaria’s lipophilic enhancement technology increases the bio-absorption of cannabinoid edibles by five to 10 times, to roughly equal that of inhalation. The onset times for effectiveness are also reduced by about 75 percent due to rapid bio-absorption by bypassing first-pass liver metabolism. Not only does Lexaria’s methodology dramatically increase effectiveness; it also masks the taste of cannabinoids and eliminates the need for sugar additives.

Lexaria currently has 19 patent applications filed in the U.S. and internationally covering 44 countries. The patents encompass a broad range of lipophilic bio-actives including NSAIDs and Nicotine, as well as food/carrier that can be formulated and delivered using Lexaria’s technology. With U.S. patents already issued, the company announced just last week that its first international patent was accepted and issued in Australia (http://dtn.fm/zjN9O). This development opens the door for Lexaria to bring the Australian cannabinoid edibles market under its umbrella.

Chris Bunka, CEO of Lexaria, stated in the news release. “We are very pleased to have received this patent which effectively covers all cannabis oil extract formulated edibles utilizing our technology in Australia…(the) patent award allows us to confidently enter the recently legalized Australian cannabis marketplace where we will seek additional licensing and product distribution partnering opportunities.”

Lexaria employs a low-cost, high-margin license and royalty model of revenue generation. By out-licensing to third party partners, the company keeps five to 10 percent of each partner’s gross sales. With multiple royalty agreements already in the works, the company will continue to expand its licensing network as it receives patent approvals. Interestingly, Lexaria’s novel technology has implications across a wide swath of consumer and pharmaceutical delivery protocols. The global impact of Lexaria’s patents and business model will easily reverberate to the bottom line and has only just begun.

For more information, visit the company’s website at www.LexariaEnergy.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

SinglePoint (SING) Sees Advantages in Bitcoin, Formation of SingleSeed.com, and Joint Venture with First Bitcoin Capital Corp.

- Company sees four to five more acquisitions in pipeline after its investment in California firms DIGS and Convectium

- Hired a blockchain expert as part of project addressing payment processes for the cannabis industry

- Hired Turner, Stone & Company LLC to complete 2016 financial audit


Wil Ralston, president of SinglePoint, Inc., (OTC: SING), and Greg Lambrecht, CEO, say their company is primed to make four to five more acquisitions as it sees further opportunity in the cannabis market and medical marijuana. It is supporting dispensaries with the cryptocurrency bitcoin and is helping legal sellers solidify an online presence with subsidiary SingleSeed.com. SinglePoint has hired a digital technology blockchain expert and will launch a project to determine a solution for payment processes within the cannabis industry.

The company’s recent online audio press release (http://dtn.fm/4lNeO) illustrates how this Seattle-based full service mobile technology provider is transitioning into a diversified holding company. It is committed to growing in the cannabis industry. It has formed a joint venture with First Bitcoin Capital Corp. (http://dtn.fm/xNi0e) to offer a payments solution using blockchain technology. The goal is to develop a proprietary solution for high-risk vertical businesses within the cannabis industry. Vancouver, Canada-based First Bitcoin Capital (OTC: BITCF) is a vertically-integrated, publicly traded bitcoin entity.

In May 2017, SinglePoint acquired 90% of discount indoor garden supply firm DIGS. That purchase put SinglePoint further into the online marketplace. That company has two brick-and-mortar store locations in California and is eyeing a third. It also has an online store, www.DIGSHydro.com. SinglePoint has also acquired a portion of Convectium (http://dtn.fm/9Bk7M). This California company creates infrastructure for firms in the cannabis market. It has developed a unique oil filling system, and its products will be sold through SinglePoint’s SingleSeed.com subsidiary.

CEO Lambrecht said SinglePoint is focused on organic growth and acquisition. He is optimistic about legislation coming from the new administration and, eventually, banks opening up to the cannabis industry. “Singlepoint is basically a mobile payments technology company, but we’re able to really jump into any vertical because almost every business has a payment option,” Lambrecht said in the release.

Lambrecht, also president, CEO and founder of SingleSeed, added that SingleSeed.com can enable cannabis retailers to process sales using bitcoin and help dispensaries use online marketing strategies such as texting and mobile phone sales. He explains how the company’s cashless ATMs on site can offer dispensaries the ease of accepting a cashless transaction with bitcoin for a cannabis or medical marijuana purchase. Revenue streams for SinglePoint are created through a transaction commission.

SinglePoint is positioned to benefit from the growth of the cannabis industry. Additionally, Lambrecht disclosed that Turner, Stone & Company, LLP, has been hired to complete an audit of SinglePoint’s financials for 2016.

For a detailed executive audio interview on the announcement, see http://dtn.fm/Rn6wb, or visit www.SinglePoint.com for additional information on the company.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Announces Launch of Neurosurgery Service Line

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced the launch of its fourth service line, marking the company’s strategically planned entry point into neurosurgery. “We are excited to announce the new Neurosurgery service line so quickly after launching our previous modules,” Colt Melby, CEO of ORHub, stated in the news release. “The need for our software in the operating room is monumental, and we are aggressively working to expand our service line offerings to deliver our transformative software to key hospitals in major U.S. markets.” The company’s portfolio of service lines now includes software solutions for Spinal, Hip & Knee, Cardiac & Cardiology and Neurosurgery. Per this morning’s update, ORHub’s addressable market related to these four service lines is expansive, including hospitals and ambulatory surgical centers that collectively perform over 100 million procedures annually. Capitalizing on the value of the ORHub Platform and its tools for helping hospitals and surgeons make real-time, data-driven decisions that improve both profitability and patient outcomes, ORHub is currently on track to exceed its deployment goal for 2017.

To view the full press release, visit http://dtn.fm/VCU8f

About ORHub, Inc.

ORHub is a cloud-based software platform focused on delivering value-based medicine in surgical care. The company enables all parties involved in surgical care to work together to organize, deliver, measure and reimburse in a single uniform process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. The need for ORHub is clear. Health care comprises more than 17% of US GDP at over $3 trillion dollars per year. With costs rising every year due to an aging population and more expensive treatments, providers are under severe pressure to become more efficient and reduce costs from payers who are aggressively reducing reimbursements and finally moving away from fee-for-service and toward performance-based reimbursement. ORHub enables providers to thrive in this new environment by addressing the single largest segment of health care, which is surgical care. ORHub replaces numerous legacy systems with a 360 degree system that is focused on tracking cost from diagnosis to discharge centered on treating a patient for a specific condition. ORHub has offices at Phoenix, Arizona; Newport Beach, California; and Bellevue, Washington. For more information, visit www.ORHub.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Monday, July 24, 2017

Global Payout, Inc. (GOHE) is Making Worldwide Financial Transactions Seamless

- Connecting a global financial market to a private banking network

- A cloud-based financial platform for trading & settlement of depositary accounts

- Using blockchain technology to deliver secure financial transactions

Banking has come a long way from the time when moneychangers set up their tables in the marketplace. The technology then was minimal: paper records of bills of exchange and letters of credit. Today, technology dominates banking. More than a quarter (about 9,000) of Goldman Sachs’ 33,000 full-time employees are engineers and programmers, by one account (http://dtn.fm/dX51Z). Its CEO is on record as saying that Goldman Sachs (NYSE: GS) is a technology firm, a pointed indication of the extent to which information technologies have permeated modern banking. To serve this growing fintech market, California-based Global Payout, Inc. (OTC: GOHE) is rapidly developing a variety of innovative products. The company is offering state-of-the-art software solutions to fintech companies involved in processing money remittances, wire transfers, bill payments, business-to-business (B2B) payments, currency exchange, eWallet payments and other types of financial transactions.

Since its inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. The company was founded by Jim Hancock, who has guided its evolution from a program management and consulting services company offering prepaid debit cards and electronic wallet products to the global, full-service payment platform it is today. Hancock is Global Payout’s current CEO and chairman. His 30 years of experience range over a variety of industries and include senior positions in investment banking, mergers and acquisitions, payment processing and telecommunications. For the last 14 years, he has successfully managed close to 40 custom-designed prepaid debit card programs. Hancock intends to leverage his vast array of contacts and in-depth knowledge of the payment industry in executing Global Payout’s new initiatives.

These began in 2014, when the company introduced its first online payment platform, called the Consolidated Payment Gateway (CPG). CPG allows its enterprise clients the capability to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of the company’s present, state-of-the-art fintech payment system in 2016, which both expands the range of financial services available to clients and offers them reduced transaction costs.

In January 2017, Global Payout announced a licensing agreement with First American Electronic Payment Solutions, Inc., producer of an innovative software system for companies wishing to process money remittances, wire transfers, bill payments, B2B transactions, eWallet payments and transfers, currency exchanges and other types of financial transactions. This collaboration provides the backbone infrastructure that supports the company’s recently introduced Global Reserve Platform (GRP), a customizable, “banking-in-a-box” web-based platform. GRP offers the capability to execute the front-to-back office processing requirements of domestic/foreign exchange and international payment service providers and is expected to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

Global Payout is connecting this worldwide cloud-based financial services platform to traditional banking. The company holds majority control of ISBC Holdings, Ltd., the sole domestic and international management company for the International Sovereign Banking Corporation (ISBC). ISBC is a privately-owned sovereign nation bank to be held on the sovereign tribal land of the Wakpamni Lake Community, Oglala Sioux Tribe located at the Pine Ridge Tribal Reservation in South Dakota.

With such a spectrum of services, Global Payout can offer traditional banking and products to businesses that cannot access those services. For example, last year, the company announced that Marijuana Company of America (OTC: MCOA) had selected Global Payout as its financial solutions provider (http://dtn.fm/bM1ZE). Global Payout’s CPG and MoneyTrac prepaid solutions will enable MCOA to process membership fees and pay vendors, employees, and affiliates. MCOA members will be able to make purchases using an MCOA-branded prepaid card, reducing cash transactions and enabling online and mobile purchases. This significantly reduces the risk associated with operating a cash-only cannabis business and the legal perils associated with the substance.

For more information, visit the company’s website at www.GlobalPayout.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

MoneyOnMobile (MOMT) Digital Mobile Payment Network Services World’s Largest Under-Banked Population

- India has world’s second-largest population at 1.35 billion

- India is largest under-banked population in the world

- MoneyOnMobile services under-banked with digital mobile payment network

- 39 percent monthly compounded revenue growth in Q1


With an average growth rate of around seven percent over the last two decades, India’s economy is the sixth-largest in the world measured by GDP and the third-largest by purchasing power. In spite of its economic prowess, the Indian consumer market is the largest under-banked population in the world. Banking services are scarce and woefully inadequate, forcing cash transactions and chocking consumer purchasing power. A prime example of scarce banking services is India’s paltry 200,000 ATMs servicing its 1.35 billion citizens. India would need two million more ATMs in order to have the same ratio of ATMs to people as in the U.S.

Since 2010, MoneyOnMobile, Inc. (OTCQX: MOMT) has been delivering needed services to India’s vast un-banked and under-banked population. MoneyOnMobile is a digital mobile phone payment network that allows consumers to deposit cash with one of its 335,000 retailers in 700+ cities. MoneyOnMobile is authorized by the Reserve Bank of India (RBI) to set up this semi-closed payment network, which enables registered users to buy goods, products and services from registered merchants.

The consumers’ cash deposits become digital currency in MoneyOnMobile’s computerized records. Consumers then have the ability to perform over 55 different transactions, including various bill payments, cash withdrawal, domestic remittances and money transfer using only their mobile phone and SMS text messaging. The system is faster, safer, more reliable, cheaper and much easier to use than transacting in all cash.

MoneyOnMobile is being embraced by the Indian un-banked and under-banked consumer, and the company’s reach into the remotest parts of India makes it the go-to prepaid instrument on the market today. The company has already served over 198 million cumulative unique mobile phone number users and has processed $1.8 billion worth of transactions. Convinced it’s just getting traction, MoneyOnMobile had 39 percent monthly compounded revenue growth in the three months from January to May 2017.

MoneyOnMobile’s cellular prepaid digital payment system is directly centered in one of highest spheres of growth in the financial services arena. The company’s no-cost to end-user services meet a vast unmet need in one of the world’s most populated countries, providing users newfound flexibility and self-dependence. It shouldn’t be long before MoneyOnMobile’s growth numbers eclipse the first three months of this year.

For more information, visit the company’s website at www.Investors.MoneyOnMobile.in

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Aims at Future of Cannabinoid Compound Treatment

- Specializing in novel cannabinoid drug therapies, InMed Pharmaceuticals is well-poised for cannabinoid research and development of new treatments

- Glaucoma and skin disease pharmaceuticals now in development have an estimated $7.6 billion potential market

- InMed Pharmaceutical’s chief medical officer helped $3 billion GW Pharmaceuticals develop one of the first cannabis-based drugs


With its proprietary bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is well-positioned to target the future of cannabinoid pharmaceutical compounds.

InMed is a pre-clinical stage biopharmaceutical company specializing in the development of novel therapies through research and development of the 90+ individual cannabinoid compounds which occur naturally in cannabis.

InMed can rapidly analyze and identify novel cannabinoids to find new drug candidates with the highest therapeutic benefit and fewest adverse effects. The company’s unique research approach using proprietary bioinformatics tools expedites the identification of bioactive compounds with the potential to treat specific diseases, while its comprehensive pharmaceutical and cannabinoid structures database allow InMed to identify active cannabinoids that will act on genes and proteins.

Two major medications are in development by InMed Pharmaceuticals: a glaucoma treatment and a drug therapy for epidermolysis bullosa (EB). The two markets combined have an estimated value of $7.6 billion. Clinical trials for both candidates are expected to start in 2018.

In June, InMed Pharmaceuticals announced an agreement with Pharmaseed Ltd. to develop the final formulation for INM-750, a treatment in development as a therapy for EB and other dermatological and wound applications.

Epidermolysis bullosa comprises a group of inherited connective tissue diseases which typically affect the skin, causing it to become extremely fragile and prone to blistering and tearing. The disease can also affect bodily systems and internal organs. There is currently no approved treatment for EB. InMed’s topical formulation includes multiple cannabinoids to target keratin modulation, as well as inflammation, healing, skin regeneration, itching, and pain.

A second pharmaceutical in InMed’s pipeline, INM-085, treats glaucoma, an eye disorder which increases pressure in the eye, damages the optic nerve and is one of the leading causes of blindness in the developed world. The glaucoma medication could become the first-ever treatment for the disease that is multi-target and uses multiple cannabinoids for maximum effectiveness.

InMed Pharmaceuticals’ impressive management team includes Chief Medical Officer Dr. Ado Muhammed, a former associate medical director for GW Pharmaceuticals. Muhammed was instrumental in leading GW Pharmaceuticals (NASDAQ: GWPH) through development and approval of one of the world’s first cannabis-based drugs, taking the company’s shares from less than $9 in 2013 to $100 today and building a market value of more than $2.5 billion.

InMed Pharmaceuticals president and CEO Eric Adams is a seasoned biopharmaceutical executive with over 25 years’ experience in company and capital formation, global market development, mergers & acquisitions, licensing and corporate governance. Adams previously served as CEO at enGene Inc. and held key senior roles in global market development with QLT Inc. (Vancouver), Advanced Tissues Science Inc. (La Jolla), Abbott Laboratories (Chicago), and Fresenius AG (Germany).

InMed’s Chief Scientific Officer Dr. Sazzad Hossain has more than 20 years of academic and industrial experience in new drug discovery and natural health product development. Hossain held key roles at the Biotechnology Research Institute of National Research Council Canada and Xenon Pharmaceuticals. CFO Jeff Charpentier is a 25-year veteran of the biopharmaceutical industry and has served at several public and private companies in the pharmaceutical and technology sectors.

With lots of opportunity, a share price of less than 30 cents and a market cap of about $34 million, InMed looks like a good opportunity to profit from what may become the next success story in the ongoing quest to cure and mitigate disease with cannabinoid-based therapeutics.

For more information, visit the company’s website at www.InMedPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Patriot One Technologies’ (TSX.V: PAT) (OTCQB: PTOTF) PATSCAN Defends Against Terrorists and Active Shooters

- PATSCAN CMR™ technology to detect concealed weapons & ordnance

- Microwave radar technology developed in collaboration with McMaster University

- Non-intrusive system units can be deployed covertly


Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is on the frontline of the fight against terrorists and active shooters, the latter defined by law enforcement agencies as ‘an individual or individuals actively engaged in killing or attempting to kill people in a populated area’. In collaboration with McMaster University of Canada, the company has developed novel technology which detects weapons and other ordnance carried into public spaces and reduces the risk posed by malevolent actors. Unlike present weapons detection systems, the Patriot One units employing this innovative technology can be deployed without the knowledge or awareness of those being scanned. In addition, there is no stop-and-scan or intrusive invasions of privacy. With its new PATSCAN technology, Patriot One is offering airports, train stations, nightclubs, concert venues and other public arenas the capability to deter, detect and defend against terrorists and active shooters.

Patriot One’s preemptive approach to warding off gun and bomb violence employs cutting-edge microwave radar technology linked to machine algorithms. The low-power radar system scans people and property as they pass through the field of the device. This data is relayed continuously to sophisticated algorithms that access a database of ordnance “signatures” and make a determination, in real time, of a possible security threat. By running the scan against the signatures in the database, the system quickly identifies whether someone is carrying a gun, knife, bomb or some other potentially dangerous device or object.

Patriot One’s PATSCAN, developed in collaboration with researchers from McMaster University, is markedly different from traditional weapons detection technology. Current weapons detection systems are highly visible and tend to create the sort of ominous atmosphere one might expect in a prison, perhaps, but not at a teenage pop concert. However, PATSCAN can be deployed covertly behind walls, ceilings and floor panels and is, in effect, invisible to the public. Consequently, it increases the likelihood that an actor with malicious intent will give himself away. The technology, which will certainly prove disruptive to the security industry, is rather less so in operation. It requires no stop-and-scan; no searching of handbags and emptying of pockets; and no body scans that may violate the norms of privacy or decency. In many ways, PATSCAN CMR is clean technology, and its merits are getting a nod from industry experts.

Earlier this year, the company announced the Security Industry Association (SIA) had recognized it as winners of the Anti-Terrorism / Force Protection category in the New Product Showcase (NPS) component of the ISC West industry trade show and conference in Las Vegas, Nevada (http://dtn.fm/8pwAK). SIA NPS judges are highly skilled and experienced in security technology design and application and are required to have a minimum of 10 years experience in the selection, purchase and or installation of products within the category that they are judging. The PATSCAN has, so far, achieved a 94 percent true positive detection, which is far ahead of traditional metal detector rates.

Patriot’s order book is growing, and inquiries from potential clients and distributors continue to pour in. Last month, one such inquiry, from Down Under, blossomed into a new partnership. Patriot One announced it had entered into a reseller agreement with accredited national systems integration experts Aotea Security (NZ) Ltd. of Dunedin, New Zealand (http://dtn.fm/7UsxI). Aotea Security is the security specialist arm of the Aotea Group of companies, which provides New Zealand’s only truly nationwide solution for electronic security, electrical, fire, and communications services.

Patriot One is now in the process of obtaining certification from Industry Canada and the Federal Communications Commission (FCC) in the U.S. for its commercial PATSCAN units. The company hopes to start shipping commercial units in the fall.

For more information, visit the company’s website at www.Patriot1Tech.com

Let us hear your thoughts: Patriot One Technologies, Inc. Message Board

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Files Record of ‘CBD Magic Hemp Series’ Product Line Ahead of Impending Launch

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). These products, which comprise the new ‘CBD Magic Hemp Series’ skin care line, are expected to launch in late August and early September of this year, positioning CBD Biotechnology as a first-mover in an untapped segment of China’s skin care industry. “As one of the first skin care products containing CBD extract marketed in China, CBD Magic Hemp Series expects to capture 100% of China’s market share in this novel skin care products category,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “Although a catalogue published by the CFDA, indicates that cannabis sativa leaf extract can legally be added to skin care products, it appears that Chinese skin care manufacturers have not yet entered this market, enabling CBD Biotechnology’s skin care products to proudly take the lead with its innovative product line.” Per the update, China currently has the world’s second-largest consumer market for skin care products, with the current market size exceeding $44.4 billion.

To view the full press release, visit http://dtn.fm/Sz28u

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ProBility Media Corp. (PBYA) Enters Binding Letter of Intent to Purchase Cranbury International

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced that it has signed a binding letter of intent to purchase Cranbury International, an exporter of educational and reference materials located in Montpelier, Vermont. The acquisition is expected to close within 30 days and will significantly expand ProBility’s reach in markets throughout South and Central America, as well as the Caribbean. Cranbury, which markets and represents roughly 40 major publishers, currently sells educational materials to government institutions and private sector markets in Brazil, Mexico, Columbia, Trinidad and other international regions. “The purchase of Cranbury complements ProBility’s international strategy of offering educational and training materials dedicated to the skilled trades and further expands our international footprint,” Evan Levine, chairman and chief executive officer of ProBility, stated in the news release. “Cranbury’s trailing twelve month revenue of approximately $1.5 million is a meaningful addition to ProBility’s revenue base as well and we anticipate synergistic growth in the coming twelve months.”

To view the full press release, visit http://dtn.fm/0kFLp

About ProBility Media Corp.
ProBility Media Corp. is an EdTech company building the first full-service training and career advancement brand for the skilled trades. Through its divisions Brown Technical Media Corp., Brown Technical Publications Inc., Brown Book Shop, Inc., National Electrical Wholesale Providers, W Marketing, One Exam Prep, LLC, ProBility Safety Academy and its partnership with Globalsim Inc., ProBility is executing a disruptive strategy of defragmenting the skilled trades training market place by offering high quality training courses and materials and preparing the workforce for excellence. ProBility services customers from the tradesman to the small business to the enterprise level corporation.

For more information, visit http://www.ProBilityIT.com, http://www.ProBilityVRware.com, and ProBilityMedia.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Friday, July 21, 2017

QualityStocksNewsBreaks – American Energy Partners, Inc. (XFUL) Subsidiaries Find Value Where Water Meets Oil & Gas

Though water is the Earth’s most abundant resource, only about one percent of the world’s fresh water is accessible for human use—making the efforts of companies like Converde Energy USA, Inc., d/b/a American Energy Partners (OTC: XFUL), incredibly valuable and crucially needed. American Energy Partners has developed a pioneering water treatment technology that is in the final stages of the patent process and offers revolutionary potential to turn the tide for drought areas and other places of need throughout the world.

“…XFUL is already on the job and, as an example of the kind of job the company can do, a recent press release (http://dtn.fm/ft8JE) sheds a revealing light. XFUL announced it was collaborating with the Eastern Pennsylvania Coalition for Abandoned Mine Reclamation (EPCAMR) and the Susquehanna River Basin Commission (SRBC) in a multi-phase study of the Mocanaqua Abandoned Mine Drainage (AMD) Tunnel. The project is designed to test the viability and safety of releasing “the millions of gallons of treated mine influenced water during low flow conditions into the local watershed that feeds the Susquehanna River in Pennsylvania”. The Mocanaqua AMD Tunnel holds a significant pool of isolated mine water thought to exceed 500 billion gallons.

“The company’s Gilbert unit (Gilbert Oil & Gas Company) continues the search for such opportunities, leveraging its broad industry valuation experience to develop partnerships with companies operating in the oil and gas space, with the emphasis on positive cash flow. XFUL’s other two subsidiaries, Hydration Company of PA (HCPA) and American Energy Solutions (AES), have a broader remit, however. Their potential markets extend far beyond oil and gas, as their services can be offered to municipalities, factories, and farming, power production and other industrial concerns. Gilbert’s activities are likely to seed the growth of HCPA and AES, since Gilbert could be their customer. This synergy is set to bootstrap XFUL on its way to becoming fully integrated and operational.”

To view the full article, visit http://dtn.fm/2W7Fw

About Converde Energy USA, Inc. (XFUL)

XFUL and its group of companies focus on providing solutions in markets where energy production and water meet technology. Collectively, the subsidiaries are engaged in the energy sector as well as the design, construction and operation of regional water treatment facilities that serve the industrial, energy and government sectors.

Hydration Corporation of PA, LLC (“HCPA”) is engaged in the businesses of water exploration, water augmentation, and the treatment of impacted waters. Notably, its intellectual property delivers one of the highest energy yields from a broad range of water-bearing assets, with one of the lowest capital expenditures of any other known water processes. American Energy Solutions, LLC provides treatment technologies that contribute to HCPA’s business model of low-cost treatment and distribution. As a provider of design, this subsidiary is capable of repeatable and synergistic services across the value chain. Gilbert Oil & Gas Company is leveraging broad industry valuation experience to source drilling, operating, and partnership opportunities in the upstream oil and gas space. It is positioned to become a strong customer of XFUL’s other subsidiaries while providing them with the foundation to attract other customers and enter new markets.

For additional information, visit: http://americanenergy-inc.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Thursday, July 20, 2017

QualityStocksNewsBreaks – ProBility Media Corp. (PBYA) Launches Joint Venture with Industrial3D Corp. to Develop Virtual Reality Education and Training Products

EdTech innovator ProBility Media (OTCQB: PBYA) is venturing into the virtual reality realm through a new joint venture with Industrial3D Corp. ProBility Immersive Technologies will create virtual reality and interactive media content designed specifically for education and training purposes. With the joint venture, ProBility’s IP library encompasses over 200 animations applicable to industries it already serves while enabling the company to offer expanded subscription services to employers for training and education in the energy and industrial sectors for the first time.

“Through our acquisition and partnership strategy, ProBility now offers a comprehensive suite of career training, career advancement and compliance tools for over 60 skilled trades. With the aggressive push from the current administration for an expansive apprenticeship program, ProBility is well positioned to benefit from the resulting expected upturn in the markets we serve. The joint venture with Industrial3D will add to and enhance our innovative proprietary technology solutions, including Virtual Reality, Digital Simulation and now 3D Imaging, as we continue to efficiently train students and prepare to meet increasing demand for our services,” ProBility chairman and CEO Evan Levine stated in the news release.

To view the full press release, visit: http://dtn.fm/vuvL8

About ProBility Media Corp.
ProBility Media Corp. is an EdTech company building the first full-service training and career advancement brand for the skilled trades. Through its divisions Brown Technical Media Corp., Brown Technical Publications Inc., Brown Book Shop, Inc., National Electrical Wholesale Providers, W Marketing, One Exam Prep, LLC, ProBility Safety Academy and its partnership with Globalsim Inc., ProBility is executing a disruptive strategy of defragmenting the skilled trades training market place by offering high quality training courses and materials and preparing the workforce for excellence. ProBility services customers from the tradesman to the small business to the enterprise level corporation.

For more information, visit http://www.ProBilityIT.com, http://www.ProBilityVRware.com,  and ProBilityMedia.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Commences Lab Work with National Research Council of Canada

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced the start of laboratory work under its collaborative research project with the National Research Council of Canada (“NRC”). “We are delighted to have commenced formulation development and characterization work together with the NRC,” John Docherty, president of Lexaria Bioscience, stated in the news release. “The NRC team has extensive knowledge and experience in the field of lipid based delivery systems relating to pharmaceutical products, natural health products and functional foods. This collaboration will significantly assist Lexaria in further developing and characterizing its IP portfolio.” Moving forward, several studies will be initiated in an effort to optimize Lexaria’s patented technology enabling delivery of lipophilic active agents within foods, beverages, capsules and other ingestible formats. Per this morning’s update, practical applications of this work could include further broadening or strengthening of Lexaria’s intellectual property portfolio and may also provide the foundation for new commercial arrangements.

To view the full press release, visit http://dtn.fm/Czhc8

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit www.LexariaBioscience.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Wednesday, July 19, 2017

American Energy Partners, Inc. (XFUL) Synergistic Subsidiaries Extracting Value at the Nexus of Water and Oil & Gas

- Synergistic subsidiaries

- Awaiting approval of water treatment patent application

- Augmented management team


Although water covers 70 percent of the Earth’s surface and is its most abundant resource, the five-year drought in California and the recent water crisis in Flint, Michigan, show that our reserves are ever under threat. With this in mind, it’s nice to know that supplies of the precious commodity for household, industrial, and agricultural use are not being taken for granted. Converde Energy USA, Inc., d/b/a American Energy Partners Inc. (OTC: XFUL), has developed water treatment technology that is in the final stages of the patent process. In addition, the company’s three divisions cleverly catalyze each other, providing the synergy for growth. With its newly augmented management team and synergistic subsidiaries, Converde Energy’s imminent name change to American Energy Partners signals the company’s strengthened position and developing momentum.

The Ancient Mariner lamented, “Water, water, everywhere, nor any drop to drink.” That is because most of it (about 97 percent) is in the oceans and too salty for drinking, growing crops, or many other human uses. Much of the other three percent is unavailable, since it is held in the ice caps of Antarctica and Greenland or in deep underground aquifers where, for most practical purposes, it is inaccessible to us. Therefore, only about one percent of the Earth’s fresh water, in rivers, lakes and accessible groundwater resources, can be tapped for human use. A lot of that, unfortunately, needs a great deal of filtration and sanitization before it’s usable.

However, XFUL is already on the job and, as an example of the kind of job the company can do, a recent press release (http://dtn.fm/d0lfA) sheds a revealing light. XFUL announced it was collaborating with the Eastern Pennsylvania Coalition for Abandoned Mine Reclamation (EPCAMR) and the Susquehanna River Basin Commission (SRBC) in a multi-phase study of the Mocanaqua Abandoned Mine Drainage (AMD) Tunnel. The project is designed to test the viability and safety of releasing “the millions of gallons of treated mine influenced water during low flow conditions into the local watershed that feeds the Susquehanna River in Pennsylvania”. The Mocanaqua AMD Tunnel holds a significant pool of isolated mine water thought to exceed 500 billion gallons.

The company’s Gilbert unit (Gilbert Oil & Gas Company) continues the search for such opportunities, leveraging its broad industry valuation experience to develop partnerships with companies operating in the oil and gas space, with the emphasis on positive cash flow. XFUL’s other two subsidiaries, Hydration Company of PA (HCPA) and American Energy Solutions (AES), have a broader remit, however. Their potential markets extend far beyond oil and gas, as their services can be offered to municipalities, factories, and farming, power production and other industrial concerns. Gilbert’s activities are likely to seed the growth of HCPA and AES, since Gilbert could be their customer. This synergy is set to bootstrap XFUL on its way to becoming fully integrated and operational.

At Gilbert’s helm is newly-appointed President Josh Hickman, who will also sit on XFUL’s board. Hickman, an oil and gas exploration geologist, is a tested deal finder and dealmaker with a solid track record of closing deals. He brings over 15 years’ experience in the oil and gas industry to the XFUL team, with stints at Consol Energy, Cabot Oil and Gas, Edgemarc Energy Holdings and Dahlmont Energy Resources under his belt. He is also the founder of Hickman Geological Consulting, which specializes in applying the principles of technical data and financial understanding to growth businesses in the oil and gas space.

For more information, visit the company’s website at www.AmericanEnergy-Inc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Shares Spike on Launch of Cardiac and Cardiology Service Line, Overall Deployment Strategy

Shares of ORHub (OTC: ORHB) are up nearly 5% after the company said that it is on track to exceed its deployment goals for 2017 with the launch of its Cardiac and Cardiology service line, the third line in its portfolio of medical software modules. ORHub’s Cardiac and Cardiology service line is expected to be available in early third quarter 2017. “The ORHub Platform helps hospitals and surgeons make real-time, data-driven decisions that improve business profitability and patient outcomes. Utilizing the resources of our new national delivery partner, we intend to expand our service line offerings at an aggressive rate and deliver our transformative software to key hospitals in major U.S. markets,” ORHub CEO Colt Melby stated in the news release.

To view the full press release, visit: http://dtn.fm/qO96R

About ORHub, Inc.

ORHub is a cloud-based software platform focused on delivering value-based medicine in surgical care. The company enables all parties involved in surgical care to work together to organize, deliver, measure and reimburse in a single uniform process. This allows for significant decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions that result from siloed processes in software and poor handoffs from one part of the care process to another. The need for ORHub is clear. Health care comprises more than 17% of US GDP at over $3 trillion dollars per year. With costs rising every year due to an aging population and more expensive treatments, providers are under severe pressure to become more efficient and reduce costs from payers who are aggressively reducing reimbursements and finally moving away from fee-for-service and toward performance-based reimbursement. ORHub enables providers to thrive in this new environment by addressing the single largest segment of health care, which is surgical care. ORHub replaces numerous legacy systems with a 360 degree system that is focused on tracking cost from diagnosis to discharge centered on treating a patient for a specific condition. ORHub has offices at Phoenix, Arizona; Newport Beach, California; and Bellevue, Washington. For more information, visit www.ORHub.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com (CIIX) Eyes Expansion in CBD Markets throughout North America

- Sees opportunities in the fast-growing international medical marijuana market

- Plans store opening in San Gabriel, California, with online hemp-based product store already in Shanghai, China, targeting the global Chinese-speaking community

- Consilium Global Research projects that company revenues will reach $14.8 million by FY2020


ChineseInvestors.com, Inc. (OTCQB: CIIX) is employing a strategy of selling cannabidiol (CBD) in North America. It plans for a brick-and-mortar store in San Gabriel, California, as well as recently incorporating CBD Biotechnology, Inc., in British Columbia, Canada. It also has an online CBD store with hemp-based products located in the free trade zone of Shanghai, China, designed to serve the global Chinese-speaking population.

CIIX offers educational and consulting services to the Chinese community. Most recently, it has been pursuing the hemp oil-based industry through its online store, its planned California unit, and now the corporation formation in Canada. The goal of the company is to be the leading Chinese publicly-traded nutritional company. CIIX is projected to reach eight-figure revenues by FY2020, according to a SeeThruEquity research report (http://dtn.fm/j4lAZ), and it is still working its core, high-margin investor relations business within the Chinese-speaking market.

However, its expansion into Canada illustrates that CIIX is eyeing, in addition to hemp-based nutritional products, opportunities in the medical marijuana market. Warren Wang, founder and chief executive officer of CIIX, said the incorporation of CBD Biotechnology in Canada is a “promising step forward” toward the company’s goals of entering the medical marijuana industry. He noted that there are nearly one million Chinese in Canada.

Investor relations and subscription levels continue to grow, the SeeThruEquity report noted, giving CIIX a foothold within the Chinese-speaking community. A research report by Consilium Global Research (http://dtn.fm/5b4qX) added that CIIX’s intimate knowledge and penetration of the native Chinese market in the U.S. and globally, “makes for an enormous and niche opportunity.” It projects company sales reaching $14.8 million by FY2020.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php